Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples